Ozempic, the brand name for semaglutide, stands as one of the most impactful weight loss and diabetes management medications introduced in recent years. By 2026, this once-weekly injectable GLP-1 receptor agonist continues to dominate discussions around sustainable weight reduction, glycemic control, and cardiometabolic health. Semaglutide mimics the action of glucagon-like peptide-1, a gut hormone that […]